SUBSCRIBE
SUBSCRIBE

Immunology and inflammation

exteriors of Merck, Biogen and BMS
Deals
Top I&I Deals So Far in 2024
The size of the global immunology market is projected to nearly double by 2032 to a quarter of a trillion dollars. Here are this year’s standout deals in the space.
August 7, 2024
 · 
5 min read
 · 
Mollie Barnes
Pictured: GSK's headquarters in London
Business
GSK, Flagship Commit $150M Upfront for Initial Development of Respiratory, Immunology Programs
Flagship Pioneering and its portfolio companies are in line to receive up to $720 million in milestones for each of the 10 programs that GSK could option, according to Monday’s announcement.
July 30, 2024
 · 
2 min read
 · 
Nick Paul Taylor
Load More
PRESS RELEASES
Press Releases
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - November 10, 2025
November 11, 2025
 · 
2 min read
Press Releases
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
November 10, 2025
 · 
1 min read
Press Releases
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
November 10, 2025
 · 
1 min read
Press Releases
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
November 10, 2025
 · 
6 min read
Press Releases
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
November 10, 2025
 · 
12 min read
Press Releases
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
November 10, 2025
 · 
17 min read
Press Releases
Marengo Late-Breaking Oral Presentation Highlights Single-Agent, Pan Tumor Activity of Invikafusp Alfa Across PD-1-Resistant Cancers in Phase 2 Clinical Trial at SITC 2025
November 10, 2025
 · 
6 min read
Press Releases
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
November 6, 2025
 · 
5 min read
Press Releases
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
November 4, 2025
 · 
3 min read
Press Releases
Apogee Therapeutics to Participate in Upcoming Conferences
November 4, 2025
 · 
1 min read
Press Releases
Marengo to Present Late-Breaking Clinical Oral Abstract at SITC 2025 Highlighting Initial Monotherapy Activity of Invikafusp Alfa in Tissue-Agnostic, TMB-High Advanced Cancers
October 31, 2025
 · 
3 min read
Press Releases
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November 2025
October 31, 2025
 · 
3 min read
Press Releases
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
October 31, 2025
 · 
14 min read
Press Releases
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
October 31, 2025
 · 
11 min read
Press Releases
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
October 23, 2025
 · 
3 min read
Press Releases
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
October 23, 2025
 · 
4 min read
Press Releases
Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late-Breaking Oral Presentation at ESMO 2025
October 20, 2025
 · 
5 min read
Press Releases
Marengo Therapeutics to Present Key Pipeline Updates at 2025 SITC Annual Meeting and Reveal First Asset from TriSTAR™ Platform Targeting Nectin-4
October 16, 2025
 · 
5 min read
Press Releases
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
October 15, 2025
 · 
4 min read
Press Releases
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
October 1, 2025
 · 
6 min read
Load More